J. Trizuljak Et Al. , "Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification," ALLERGY , vol.75, no.8, pp.1927-1938, 2020
Trizuljak, J. Et Al. 2020. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. ALLERGY , vol.75, no.8 , 1927-1938.
Trizuljak, J., Sperr, W. R., Nekvindova, L., Elberink, H. O., Gleixner, K., Gorska, A., ... Lange, M.(2020). Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. ALLERGY , vol.75, no.8, 1927-1938.
Trizuljak, Jakub Et Al. "Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification," ALLERGY , vol.75, no.8, 1927-1938, 2020
Trizuljak, Jakub Et Al. "Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification." ALLERGY , vol.75, no.8, pp.1927-1938, 2020
Trizuljak, J. Et Al. (2020) . "Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification." ALLERGY , vol.75, no.8, pp.1927-1938.
@article{article, author={Jakub Trizuljak Et Al. }, title={Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification}, journal={ALLERGY}, year=2020, pages={1927-1938} }